Japanese Insurance Stock News

What recent performance says about DAIHEN (TSE:6622) With no single headline event driving attention today, DAIHEN (TSE:6622) is drawing interest because its share price has moved sharply in both directions over different periods, including a 17.4% decline over the past month. See our latest analysis for DAIHEN. That recent 17.4% 1 month share price decline sits against a 20.0% 3 month share price return and a very strong 86.65% 1 year total shareholder return. This suggests some momentum has...

Recent share performance context Kioxia Holdings (TSE:285A) has drawn attention after a sharp share price swing, with the stock showing a 4.2% decline over the past day and a 9.3% drop over the past week. See our latest analysis for Kioxia Holdings. Despite the recent pullback, with a 5.6% 1 month share price return decline, Kioxia Holdings still shows strong momentum when viewed over the year, highlighted by a 77.6% 3 month share price return and a very large 1 year total shareholder...

Event context and recent share performance Honda Motor (TSE:7267) has been drawing attention after recent share price swings, with the stock up around 1.5% over the past day but showing weaker performance over the past month and past 3 months. For investors, that mix of short term strength and recent declines raises questions about how current expectations around earnings, cash flows, and long term demand for Honda’s automobiles, motorcycles, and power products are being reflected in the...

Hokuriku Electric Power (TSE:9505) cut its profit outlook for the year ending March 31, 2026, after deciding to abolish the Fukui Thermal Power Station Mikuni Unit 1 and recognize related impairment losses. See our latest analysis for Hokuriku Electric Power. The board’s decision on Mikuni Unit 1 and the resulting downgrade to profit guidance comes against a backdrop of a 13.31% 90 day share price return and a 94.79% 3 year total shareholder return. This suggests recent momentum has built on...

Ono Pharmaceutical has submitted a manufacturing and marketing application in Japan for ripretinib, an oral tyrosine kinase inhibitor for advanced gastrointestinal stromal tumor that has progressed after prior chemotherapy, supported by positive global Phase 3 INVICTUS data showing significantly prolonged progression-free survival versus placebo. The filing is reinforced by ripretinib’s orphan drug status and its designation as a high medical-need therapy in Japan, highlighting its potential...

Investors may be wondering if ASICS at ¥4,306 is still offering value after its strong run, or if most of the easy gains are now behind it. The share price shows a mix of short term pressure and longer term strength, with a 2.2% decline over 7 days and a 7.8% decline over 30 days, set against an 11.9% gain year to date and a 35.9% return over the last year. Over a multi year horizon the stock has delivered very large returns, with the 3 year performance and the 5 year performance each...

Wondering if Sumitomo Mitsui Financial Group's current share price reflects its true worth, or if the market is mispricing this major Japanese bank. The stock closed at JP¥5,246 recently, with a 1.7% gain over the last 7 days, a 7.9% decline over 30 days, and returns of 1.2% year to date and 35.8% over the past year, while the 3 year and 5 year returns stand at 223.9% and 384.4% respectively. Recent coverage around large Japanese banks has focused on how investors are reassessing financial...

If you are wondering whether Daiichi Sankyo Company is attractively priced or simply reflecting its risks, the recent share performance provides a useful starting point before assessing valuation. The stock last closed at ¥2,930, with a 0.9% gain over the past week, a 2.2% decline over 30 days, and year-to-date and 1-year returns of 17.0% and 19.2% declines respectively, as well as a 37.0% decline over 3 years and a 0.7% decline over 5 years. Recent coverage around Daiichi Sankyo has focused...

TIER IV and Isuzu Motors (TSE:7202) have announced Level 4 autonomous buses built on the NVIDIA DRIVE Hyperion platform, highlighting Isuzu’s push into higher automation for its ERGA electric and diesel public transit models. See our latest analysis for Isuzu Motors. Despite the excitement around Level 4 autonomous buses, Isuzu Motors’ 1-month share price return of a 19.08% decline and year-to-date weakness suggest fading short-term momentum, while the 5-year total shareholder return of...

Earlier this week, Formentera Partners and INPEX announced a joint venture to accelerate development of onshore natural gas resources in Australia’s Beetaloo Basin, with INPEX gaining acreage through a staged earn-in to support domestic supply and potential LNG exports. This partnership combines Formentera’s shale development capabilities with INPEX’s LNG project experience, potentially creating a new, scalable gas hub that could influence the company’s long-term resource mix and...

It looks like Idemitsu Kosan Co.,Ltd. ( TSE:5019 ) is about to go ex-dividend in the next day or so. The ex-dividend...

Why Sumitomo (TSE:8053) Is On Investors’ Radar Today Sumitomo (TSE:8053) has drawn fresh attention after recent share price moves, with the stock up 1.8% over the past day and 5.1% over the past week, while showing mixed month and past 3 months performance. See our latest analysis for Sumitomo. At the current share price of ¥5,991.0, Sumitomo’s recent strength, with a 7.6% year to date share price return and 72.2% 1 year total shareholder return, points to momentum that contrasts with its...

Last week, you might have seen that DIC Corporation ( TSE:4631 ) released its full-year result to the market. The early...

Terumo Corporation ( TSE:4543 ) is about to trade ex-dividend in the next 2 days. The ex-dividend date is two business...

Investors in Unicharm Corporation ( TSE:8113 ) had a good week, as its shares rose 2.8% to close at JP¥945 following...

Investors in Japan Tobacco Inc. ( TSE:2914 ) had a good week, as its shares rose 2.2% to close at JP¥5,978 following...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Nintendo (TSE:7974) has reduced Switch 2 production targets after an initial post-launch surge. The shift comes despite early game successes, including the strong reception of Pokémon Pokopia. Management is reassessing long term demand for the console and its software lineup. Nintendo, best known for its Switch hardware and franchises like Mario, Zelda and Pokémon, sits at the intersection of console hardware and first party software. The decision to pull back on Switch 2 production after a...

NEC X selected startups for Batch 15 of its Elev X! Ignite AI venture program in Silicon Valley, focusing on AI-based solutions across multiple industries. NEC Corporation of America upgraded Western Identification Network’s biometric identification platform, aiming to modernize law enforcement and public safety workflows. For investors following NEC Corporation, TSE:6701, these updates point to two connected areas of activity: AI ventures through NEC X and public safety technology through...

Tokai Carbon Co., Ltd. was recently removed from the FTSE All-World Index, while its board met on March 27, 2026 to discuss disposing of treasury shares as restricted stock remuneration. This combination of index exclusion and a shift toward equity-based compensation could subtly reshape how investors view the company’s profile and governance. Next, we will examine how Tokai Carbon’s removal from the FTSE All-World Index influences its investment narrative and broader investor...

Rakuten Group: recent performance snapshot Rakuten Group (TSE:4755) has drawn attention after a mixed stretch for the share price, with a small move over the past week but negative returns over the past month and past 3 months. See our latest analysis for Rakuten Group. At a share price of ¥749.1, Rakuten Group’s recent 1 day gain contrasts with a 1 month share price return decline of 8.3% and a 1 year total shareholder return decline of 15.33%, suggesting momentum has faded after earlier...

Why Santen Pharmaceutical Is On Investor Radars Santen Pharmaceutical (TSE:4536) has drawn fresh attention after recent share price moves, with the stock up over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation. See our latest analysis for Santen Pharmaceutical. At a share price of ¥1,792.0, Santen Pharmaceutical has seen short term momentum pick up, with a 1-day share price return of 1.96% and a year to date share price return of 8.87%...

In March 2026, global markets are navigating through a period of heightened uncertainty with U.S. equity indexes finishing lower amid geopolitical tensions and inflation concerns, while central banks signal caution in response to volatile energy prices. Despite these challenges, the search for undiscovered gems continues as investors look for stocks that demonstrate resilience and potential growth amidst these complex market dynamics. Identifying such stocks often involves assessing their...

Mitsubishi (TSE:8058) has recently drawn investor attention after a strong stretch of share price returns, with the stock showing double digit gains over the past month and over the past 3 months. See our latest analysis for Mitsubishi. The recent 10.2% 1 month share price return and 60.2% 3 month share price return sit within a stronger backdrop, with year to date share price returns of 54.8% and a very large 5 year total shareholder return, indicating strong positive momentum. If...